期刊文献+

小鼠白蛋白增强子在肝癌细胞系中无增强功能 被引量:1

Mouse albumin enhancer lost its enhancement function in hepatoma cell line
原文传递
导出
摘要 目的 :鉴定小鼠白蛋白增强子序列在肝癌细胞系中对白蛋白启动子转录活性的影响。方法 :以绿色荧光蛋白 (GFP)基因作为报告基因 ,将小鼠白蛋白增强子序列 (_10 .2 1~_8.4 3kb)之间的不同区段与白蛋白启动子相融合 ,转染不同组织来源细胞系 ,用荧光显微镜和流式细胞仪分别对GFP的表达情况进行分析。结果 :瞬时转染小鼠肝癌细胞系Hepa 1_6 ,上游的不同增强子区段均不能增强白蛋白启动子的转录活性 ,相反 ,它们都不同程度地下调了启动子的转录活性 ;稳定转染期 ,E1E3能极弱地增强启动子的转录活性。稳定转染人肝癌细胞系HepG2 ,上游的不同增强子区段均能抑制白蛋白启动子的转录活性 ,导致报告基因不能表达。在非肝脏组织的细胞系中 ,小鼠白蛋白启动子无转录活性。结论 :只使用白蛋白启动子在肝癌细胞系中表达目的基因较同时使用白蛋白启动子和增强子效果会更好。 Objective:To identify the enhancement function of mouse albumin enhancer in the transcription activity of albumin promoter in hepatoma cell lines. Methods:Green fluorescent protein (GFP) gene was used as a reporter gene to study the enhancement function of mouse albumin enhancer in the cells derived from the different tissues. Mouse albumin enhancer fragments of -10.21?kb to -8.43?kb and albumin promoter were fused with the 5′-end of GFP gene in vector pEGFP-C1. The identified recombinant vector and its control vector only containing albumin promoter were transfected into Hepa 1-6 (mouse hepatoma cell line), HepG2 (human hepatoma cell line), CHO (Chinese hamster ovary cell line) and PLA801(human lung cancer cell line), respectively. Results:Albumin promoter could drive GFP transient and stable expression in Hepa 1-6 and HepG2, but could not drive GFP stable expression not in CHO and PLA801. These enhancer fragments could not enhance the transcription of albumin promoter when transiently transfected in Hepa 1-6 and stably transfected in HepG2. On the contrary, these enhancer fragments suppressed the transcription activity of mouse albumin promoter. Albumin promoter can not transcribe the interest gene in non-liver derived cell lines. Conclusion:It is better to use only albumin promoter to express a gene in hepatoma cell lines than to use albumin promoter and its enhancer.
出处 《军事医学科学院院刊》 CSCD 北大核心 2003年第6期425-428,共4页 Bulletin of the Academy of Military Medical Sciences
关键词 白蛋白类 增强子 启动子(遗传学) 绿色荧光蛋白 转染 肝肿瘤 albumin enhancer promoter(genetics) green fluorescent protein transfection liver neoplasm
  • 相关文献

参考文献8

  • 1[1]Vorachek WR, Steppan CM, Lima M, et al. Distant enhancers stimulate the albumin promoter through complex proximal binding sites[J]. J Biol Chem, 2000,275(37):29031-29041.
  • 2[2]Muglia L, Locker J. Developmental regulation of albumin and alpha-fetoprotein gene expression in the rat[J]. Nucleic Acids Res, 1984,12(17): 6751-6762.
  • 3[3]Izban MG, Papaconstantinou J. Cell-specific expression of mouse albumin promoter[J]. J Biol Chem, 1989,264(16):9171-9179.
  • 4[4]Pinkert CA, Ornitz DM, Brinster RL, et al. An albumin enhancer located 10kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice[J]. Genes Dev, 1987, 1(3):268-276.
  • 5[5]Hu JM, Camper SA, Tilghman SM, et al. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes[J]. Cell Growth Differ,1992,3(9):577-588.
  • 6[6]Herbst RS, Friedman N, Darnell JE Jr, et al. Positive and negative regulatory elements in the mouse albumin enhancer[J]. Proc Natl Acad Sci USA,1989,86(5):1553-1557.
  • 7[7]Herbst RS, Boczko EM, Darnell JE Jr, et al. The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein[J]. Mol Cell Biol, 1990,10(8): 3896-3905.
  • 8[8]http://www.clontech.com/techinfo/vectors/vectorsE/pEGFP-C1.shtml [DB/OL].

同被引文献18

  • 1Kolykhalov AA, Agapov EV, Blight KJ,. et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA[J]. Science, 1997,277(5325):570.
  • 2McCaffrey AP, Ohashi K, Meuse L, et al. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice[J]. Mol Ther, 2002,5(6):676.
  • 3Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor[J]. Proc Natl Acad Sci USA, 1999,96(22):12766.
  • 4Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81[J]. Science, 1998,282(5390):938.
  • 5Yeh CT, Lai HY, Chen TC, et al. Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell line[J]. J Virol, 2001,75(22):11017.
  • 6Izban MG, Papaconstantinou J. Cell-specific expression of mouse albumin promoter[J], JBiol Chem, 1989,264(16):9171.
  • 7Herbst RS, Friedman N, Darnell JE Jr, et al. Positive and negative regulatory elements in the mouse albumin enhancer[J]. Proc Natl Acad Sci USA, 1989,86(5):1553.
  • 8Kramer MG, Barajas M, Razquin N, et al. In vitro and in vivo comparative study of chimeric liver-specific promoters[J]. Mol Ther, 2003,7(3):375.
  • 9Alino SF, Crespo A, Dasy F. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA[J]. Gen Ther, 2003,10(19):1672.
  • 10Stoll SM, Sclimenti CR, Baba EJ. Epstein-Barr virus/human vector provides high-levellong-term expression of alpha1-antitrypsin in mice[J]. Mol Ther, 2001;4(2):122.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部